nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—trigeminal nerve—intracranial aneurysm	0.838	0.918	CbGeAlD
Clenbuterol—NGF—brain—intracranial aneurysm	0.0526	0.0576	CbGeAlD
Clenbuterol—ADRB1—brain—intracranial aneurysm	0.0137	0.015	CbGeAlD
Clenbuterol—TNF—Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.0133	0.153	CbGpPWpGaD
Clenbuterol—CYP1A1—brain—intracranial aneurysm	0.00883	0.00967	CbGeAlD
Clenbuterol—TNF—Ceramide signaling pathway—ASAH1—intracranial aneurysm	0.0065	0.0751	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—CST3—intracranial aneurysm	0.00453	0.0523	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.00438	0.0506	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—NCF1—intracranial aneurysm	0.00373	0.0431	CbGpPWpGaD
Clenbuterol—ADRB1—Endothelin Pathways—EDNRA—intracranial aneurysm	0.00351	0.0406	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—NOS3—intracranial aneurysm	0.0032	0.037	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—AGER—intracranial aneurysm	0.00293	0.0339	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.00211	0.0243	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STARD13—intracranial aneurysm	0.002	0.0231	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP2—intracranial aneurysm	0.002	0.0231	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—CCL2—intracranial aneurysm	0.00187	0.0216	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—CCL2—intracranial aneurysm	0.00169	0.0196	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.00158	0.0183	CbGpPWpGaD
Clenbuterol—ADRB1—Endothelin Pathways—NOS3—intracranial aneurysm	0.00154	0.0178	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Other—EDNRA—intracranial aneurysm	0.00153	0.0176	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP9—intracranial aneurysm	0.00151	0.0174	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.00145	0.0167	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—intracranial aneurysm	0.0014	0.0162	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—intracranial aneurysm	0.00131	0.0152	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00125	0.0144	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—MMP9—intracranial aneurysm	0.00121	0.014	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—CCL2—intracranial aneurysm	0.00118	0.0136	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00114	0.0132	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STARD13—intracranial aneurysm	0.00104	0.012	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000979	0.0113	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.000937	0.0108	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.000904	0.0104	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000746	0.00861	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CCL2—intracranial aneurysm	0.000741	0.00856	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000678	0.00783	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000664	0.00766	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STARD13—intracranial aneurysm	0.000615	0.0071	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STARD13—intracranial aneurysm	0.000602	0.00695	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000581	0.00671	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000568	0.00656	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00053	0.00612	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000494	0.0057	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000482	0.00557	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NCF1—intracranial aneurysm	0.000463	0.00534	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000443	0.00511	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EDNRA—intracranial aneurysm	0.000437	0.00504	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000433	0.005	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000421	0.00487	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000383	0.00442	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCL2—intracranial aneurysm	0.000367	0.00424	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC25A16—intracranial aneurysm	0.000332	0.00383	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000315	0.00363	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000286	0.00331	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00028	0.00323	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00025	0.00289	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000245	0.00282	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NCF1—intracranial aneurysm	0.000239	0.00276	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000227	0.00262	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000226	0.00261	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—intracranial aneurysm	0.000224	0.00259	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000222	0.00257	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ASAH1—intracranial aneurysm	0.00022	0.00254	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL2—intracranial aneurysm	0.000218	0.00252	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL2—intracranial aneurysm	0.000215	0.00249	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL2—intracranial aneurysm	0.000213	0.00246	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	0.000212	0.00244	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NOS3—intracranial aneurysm	0.000192	0.00222	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL2—intracranial aneurysm	0.000189	0.00218	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—intracranial aneurysm	0.000169	0.00195	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—intracranial aneurysm	0.000154	0.00178	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NCF1—intracranial aneurysm	0.000142	0.00164	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	0.00014	0.00162	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NCF1—intracranial aneurysm	0.000139	0.0016	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000134	0.00155	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000131	0.00152	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000112	0.00129	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL2—intracranial aneurysm	0.000111	0.00129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL2—intracranial aneurysm	0.000109	0.00126	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOS3—intracranial aneurysm	9.93e-05	0.00115	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—intracranial aneurysm	7.96e-05	0.00092	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—intracranial aneurysm	6.61e-05	0.000763	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—intracranial aneurysm	6.47e-05	0.000747	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOS3—intracranial aneurysm	5.89e-05	0.00068	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOS3—intracranial aneurysm	5.76e-05	0.000666	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—intracranial aneurysm	4.73e-05	0.000546	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—intracranial aneurysm	4.62e-05	0.000534	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NOS3—intracranial aneurysm	4.59e-05	0.00053	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NOS3—intracranial aneurysm	2.92e-05	0.000338	CbGpPWpGaD
